In a novel ex vivo model of tumor growth in bone metastases, adding AM increased the growth of tumor in bone and stimulated expression of the osteoclast marker tartrate-resistant acid phosphatase (TRAP) only in the presence of tumor while changing the cell source of the osteoclast regulator, receptor activator of nuclear factor κB ligand (RANKL). Here, ACP5 is linked to neoplasm.